Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

FDA Warns Only 5 Chemists in One Critical Lab – Result of Shutdown

As a preventative step, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired a lot of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320milligrams into the hospital, retail and customer level. This recall of numerous batches of Valsartan Tablets was motivated as a result of discovery of trace quantities of N-Nitrosodimethylamine (NDMA), a potential procedure impurity or contaminant within an active pharmaceutical ingredient, made by Hetero Labs Limited, Unit — I (API maker ).

Source link


Please enter your comment!
Please enter your name here